14 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Design and synthesis of inhibitors of Plasmodium falciparum N-myristoyltransferase, a promising target for antimalarial drug discovery.

Imperial College
Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region.

Chinese Academy of Sciences
Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.

G. D. Searle Research and Development
Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.

University of Dundee
3D-QSAR and molecular docking studies on benzothiazole derivatives as Candida albicans N-myristoyltransferase inhibitors.

Second Military Medical University
How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using

Johannes Gutenberg-Universit£T Mainz
Novel biologically active nonpeptidic inhibitors of myristoylCoA:protein N-myristoyltransferase.

G.D. Searle And
Design and synthesis of high affinity inhibitors of Plasmodium falciparum and Plasmodium vivax N-myristoyltransferases directed by ligand efficiency dependent lipophilicity (LELP).

Imperial College
Emerging New Targets for the Treatment of Resistant Fungal Infections.

Second Military Medical University
Interrogating the Roles of Post-Translational Modifications of Non-Histone Proteins.

Temple University
PYRIMIDINE COMPOUND AS WEE-1 INHIBITOR

Wigen Biomedicine Technology (Shanghai) Co.
Peptidomimetic 2-cyanopyrrolidines as potent selective cathepsin L inhibitors.

The M. S. University of Baroda
Structural optimization of thiol-based inhibitors of glutamate carboxypeptidase II by modification of the P1' side chain.

Mgi Pharma